 ABINGDON, OXFORDSHIRE ACCESSWIRE June 9, 2020 Midatech Pharma PLC MTPH.L MTP the Company, a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines announces that last night it received a letter purporting to terminate the agreement between Secura Bio Inc. Secura Bio and Midatech Limited, a subsidiary of the Company, dated 5 June 2017 the Letter, related to the licence of certain patents of panobinostat, the active pharmaceutical ingredient of Midatechs development product codenamed MTX110 Licence Agreement. The Company regards the purported termination as entirely without merit and will take all available action to protect its rights and assets. 